Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients.
Homin KangJungyo SuhDalsan YouIn Gab JeongBumsik HongJun Hyuk HongHanjong AhnBumjin LimPublished in: Investigative and clinical urology (2024)
Thus, older age and presence of DM are potential risk factors for GP NAC discontinuation in patients with MIBC. Further studies are required to validate our findings and develop strategies to minimize the rate of GP NAC discontinuation in this population.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- muscle invasive bladder cancer
- transcription factor
- newly diagnosed
- chronic kidney disease
- ejection fraction
- lymph node
- sentinel lymph node
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- rectal cancer
- patient reported outcomes
- risk assessment
- climate change
- skeletal muscle
- insulin resistance
- glycemic control